Global Zinc Chelates Market Report and Forecast 2024-2032

Global Zinc Chelates Market Outlook

The global zinc chelates market is expected to grow at a CAGR of 5.50% in the forecast period between 2024 and 2032, owing to the increasing awareness regarding zinc deficiency amongst people.

Key Trends in the Market

Chelated zinc is essentially zinc supplements that are primarily used to treat human and animal zinc deficiencies. Chelated minerals are made up of water-soluble organic minerals, which is why they are readily absorbed. Human consumption of zinc chelates treat zinc deficiencies, improve immune system function, promote better management of blood sugars, and improve heart health. Animals who consume zinc methionine chelate benefit from its ability to increase immunity, maintain healthy skin and hooves, build their muscles, produce milk, and reproduce.

• Over the course of the forecast period, it is anticipated that there will be a rise in demand for zinc chelates due to rising consumer awareness of zinc deficiency and the nutritional benefits of zinc chelates for both animals and humans.

• One of the main minerals utilised in animal feed is zinc. It aids in protein synthesis and is crucial in improving the capabilities of defence enzymes. Therefore, increased consumer spending, high animal product consumption, and a thriving animal feed industry are expected to boost zinc chelates market expansion.

• The rising market demand for high-quality meat or poultry products, combined with a number of product improvements, such as the introduction of natural and organic feed items is propelling the zinc chelates market growth.

• Additional factors, such as the agriculture sector's rapid expansion and intense research and development (R&D) efforts, are predicted to fuel market growth. Chelated zinc fertilisers are commonly used in agriculture for higher yields by supporting plant growth.

Global Zinc Chelates Market Analysis

Based on type, the market is segmented into amino acid and organic acids, among others. The market on the basis of application can be segmented into animal feed, nutraceuticals and dietary supplements, and agriculture, among others. Animal feed is further segmented into zinc picolinate, zinc citrate, zinc acetate, zinc glycerate, and zinc monomethionine, among others. The regional market for zinc chelates can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global zinc chelates market, covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.  

• Zinpro Corporation

• Balchem Inc.,

• Nouryon

• BASF SE

• Dow Chemical Company

• Innophos Holdings, Inc.

• Alltech, Inc

• JH Biotech Inc.

• Novus International, Inc.

• Titan Biotech Ltd.

• Others

Market Share by Application

During the forecast period, animal feed segment is anticipated to witness significant growth in the overall market for zinc chelates. Large outbreaks of diseases like foot-and-mouth disease and avian flu among livestock and poultry have a negative impact on productivity, fertility, and mortality rates. The aforementioned factors are projected to result in an increase in the need for animal feed additives, which is subsequently anticipated to enhance demand for zinc chelates market throughout the course of the forecast period.

Zinc chelates usage in nutraceuticals and dietary supplements is expected to rise because they have a number of advantages. Compared to other supplements that employ zinc as a raw ingredient, chelated zinc is better absorbed in tissue and retained for longer. Zinc chelates have additional advantages such as superior antioxidant qualities with improved absorption and retention, cellular protective abilities, and other health advantages ranging from skin health to immunological function. This is expected to aid the nutraceuticals and dietary supplements segment growth over the forecast period.

Market Share by Region

The Asia Pacific is anticipated to be one of the leading regions in the zinc chelates market. The market in the region is anticipated to be driven by rising consumer expenditure, increasing demand for animal products, and a thriving animal feed industry. Further, the market expansion in the region is predicted to be aided by rising production and exports of feed additives from nations like China and Japan. 

Over the past few years, meat consumption has increased in several European nations, including Germany, France, and Italy. This has prompted manufacturers to look for disease-free and superior animal products. Additionally, it is projected that the market for feed additives in the area will be driven by the increased demand for high-quality meat and meat products. This is then anticipated to increase the industry's use of zinc chelates in animal feed additives in Europe.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

Zinpro Corporation is a global leader in supporting the health of bovine, swine, equine, and poultry, with headquarters in Minnesota in the United States. It was established in 1971 and offers animal nutritional additives. The business focuses on minerals for dairy, cattle, poultry, swine, horses, and companion animals.

Balchem Inc., an American firm founded in 1967, develops, produces, distributes, and markets specialty performance chemicals and goods for the animal health, nutritional, food, plant nutrition, pharmaceutical, medical device sterilisation, and industrial sectors.

Nouryon, headquartered in Netherlands, contributes to the provision of necessary solutions that its clients use to produce goods used in daily life, including personal care, pharmaceuticals, cleaning, agricultural and food, paints and coatings, and building products.

Other market players include BASF SE, Dow Chemical Company, Innophos Holdings, Inc., Alltech, Inc, JH Biotech Inc., Novus International, Inc., and Titan Biotech Ltd., among others.

Key Highlights of the Report